Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136)
Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136)
Active, not recruiting · NCT03775096 · Registry updated 2026-03-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136) | Nerve Degeneration, Parasomnias, Parkinson disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, REM Sleep Parasomnias, REM sleep behavior disorder, autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, primary dysautonomia, psychiatric disorder, secondary Parkinson disease, sleep-wake disorder, synucleinopathy | Active, not recruiting | Phase 2 | 2026-03-02 | NCT03775096 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Michele Tagliati, MD | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Michele L Lima Gregorio | Los Angeles | United States | 3 |